Intravenous methylprednisolone as a transition treatment in red ear syndrome: A case report Kırmızı kulak sendromunun geçiş tedavisinde intravenöz metilprednizolon: Bir olgu sunumu

Kokar S., UYGUNOĞLU U.

Agri, cilt.35, sa.4, ss.265-268, 2023 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 4
  • Basım Tarihi: 2023
  • Doi Numarası: 10.14744/agri.2021.23911
  • Dergi Adı: Agri
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.265-268
  • Anahtar Kelimeler: Facial pain, headache disorders, sphenopalatine ganglion, stellate ganglion, steroid
  • Marmara Üniversitesi Adresli: Evet

Özet

Red ear syndrome (RES) is a rare condition of unknown etiology characterized by episodic attacks of unilateral ear pain, redness, and burning sensation. A 31-year-old male patient was admitted to our clinic with a severe headache reaching up to 5 h, presenting with short bursts of electric shock-like sensation, burning, and tingling in the left side of his face. The patient was unresponsive to previous medical treatments. Lidocaine 10% through the intranasal route for sphenopalatine ganglion and stellate ganglion blockade under the guidance of fluoroscopy also failed. Given that the Red-Ear syndrome shares similar pathophysiological pathways with trigeminal autonomic cephalalgias, the patient was treated with high-dose intravenous methylprednisolone, and since then, he has been symptom-free for 6 months. High-dose steroid therapy might be a good alternative in late-onset RES as a transition treatment.